Yüklüyor......
Effectiveness of Short-Course Meglumine Antimoniate (Glucantime(®)) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran
The World Health Organization's (WHO) recommendation is 28-day course of meglumine antimoniate (Glucantime(®), Sanofi Aventis, France) for the treatment of visceral leishmaniasis (VL). The aim of this study was to evaluate the effectiveness of a shorter duration of treatment in regions with low...
Kaydedildi:
| Yayımlandı: | Am J Trop Med Hyg |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The American Society of Tropical Medicine and Hygiene
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5239690/ https://ncbi.nlm.nih.gov/pubmed/27879460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.16-0345 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|